CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Neuroimmunology

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JNEUROIM.2007.04.017PMID 17524498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population.

  2006cited by this paper
• No evidence of a significant role for CTLA-4 in multiple sclerosis.

  2006cited by this paper
• Functional evaluation of the autoimmunity-associated CTLA4 gene: the effect of the (AT) repeat in the 3'untranslated region (UTR).

  2006cited by this paper
• Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study.

  2006cited by this paper
• The CTLA4+49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland.

  2006cited by this paper
• Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients.

  2005cited by this paper
• The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders.

  2005cited by this paper
• CTLA-4 gene polymorphism is not associated with conventional multiple sclerosis in Japanese.

  2005cited by this paper
• Ctla4 and multiple sclerosis in the Italian population.

  2005cited by this paper
• A two-stage study on multiple sclerosis susceptibility and chromosome 2q33

  2004cited by this paper
• Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients.

  2004cited by this paper
• Progression of multiple sclerosis is associated with exon 1 CTLA‐4 gene polymorphism

  2004cited by this paper
• CTLA-4 AT-Repeat Polymorphism Reduces the Inhibitory Function of CTLA-4 in Graves' Disease

  2003cited by this paper
• CTLA4 is associated with susceptibility to multiple sclerosis.

  2003cited by this paper
• Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region.

  2003cited by this paper
• Genetic interaction of CTLA‐4 with HLA‐DR15 in multiple sclerosis patients

  2003cited by this paper
• Pedigree disequilibrium tests for multilocus haplotypes

  2003cited by this paper
• CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis.

  2003cited by this paper
• New diagnostic criteria for multiple sclerosis

  2002cited by this paper
• CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosis.

  2002cited by this paper
• Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence.

  2002cited by this paper
• No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study.

  2002cited by this paper
• CTLA4 dimorphisms and the multiple sclerosis phenotype.

  2002cited by this paper
• CTLA4 in multiple sclerosis.: Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese

  2001cited by this paper
• CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms

  2001cited by this paper
• CTLA-4 Gene Polymorphism at Position 49 in Exon 1 Reduces the Inhibitory Function of CTLA-4 and Contributes to the Pathogenesis of Graves’ Disease1

  2000cited by this paper
• Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis.

  2000cited by this paper
• CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis.

  1999cited by this paper
• The CTLA-4 gene is associated with multiple sclerosis.

  1999cited by this paper
• CTLA-4: a negative regulator of autoimmune disease

  1996cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper

• CCR5 Δ32 and CTLA-4 +49 A/G Gene Polymorphisms and Interferon-β Treatment Response in Croatian and Slovenian Multiple Sclerosis Patients

  2024cites this paper
• Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice

  2023cites this paper
• The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis

  2022cites this paper
• CTLA-4: From mechanism to autoimmune therapy.

  2020cites this paper
• Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression.

  2019cites this paper
• Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.

  2019cites this paper
• The Novel Short Isoform of Securin Stimulates the Expression of Cyclin D3 and Angiogenesis Factors VEGFA and FGF2, but Does Not Affect the Expression of MYC Transcription Factor

  2018cites this paper
• Correlation between CTLA-4 gene rs221775A>G single nucleotide polymorphism and multiple sclerosis susceptibility. A meta-analysis

  2016cites this paper
• Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.

  2015cites this paper
• Investigation of CTLA‐4 and CD86 gene polymorphisms in Iranian patients with brucellosis infection

  2014cites this paper
• Genetics of primary progressive multiple sclerosis.

  2014influential citation
• CTLA-4 Gene and the Susceptibility of Multiple Sclerosis: An Updated Meta-analysis Study Including 12,916 Cases and 15,455 Controls

  2014cites this paper
• Genetics of rheumatoid arthritis in black South Africans

  2014cites this paper
• CTLA-4 +49 A/G and −318 C/T polymorphisms and susceptibility to multiple sclerosis: a meta-analysis

  2013cites this paper
• Association of CD28 and CTLA-4 gene polymorphisms with aggressive periodontitis in Brazilians.

  2013cites this paper
• CTLA‐4 +49 A/G gene polymorphism in Croatian and Slovenian multiple sclerosis patients

  2011influential citation
• Interaction between CTLA4 gene and IBD5 locus in Hungarian Crohn’s disease patients

  2011cites this paper
• T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients

  2011cites this paper
• CTLA-4 gene polymorphisms (-318C/T, +49A/G, +6230A/G) in Iranian patients with multiple sclerosis.

  2010cites this paper
• Interleukin 7 receptor alpha polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans

  2010cites this paper
• Type 1 diabetes mellitus and multiple sclerosis: common etiological features

  2009cites this paper
• The CTLA‐4 gene polymorphisms are associated with CTLA‐4 protein expression levels in multiple sclerosis patients and with susceptibility to disease

  2009cites this paper
• An African Ancestry-Specific Allele of CTLA4 Confers Protection against Rheumatoid Arthritis in African Americans

  2009cites this paper
• The Soluble CTLA-4 Receptor and its Emerging Role in Autoimmune Diseases

  2009cites this paper
• An African ancestry-specific al lele of CTLA4 confers protection against rheumatoid arthritis in

  2009cites this paper
• Genes and acute neurologic disease and injury: a primer for the neurologic intensive care nurse.

  2008cites this paper
• Genomic regulation of CTLA4 and multiple sclerosis.

  2008cites this paper
• Lack of Association between Promoter Gene Polymorphism (-318 C/T) and Multiple Sclerosis in Iranian Population

  2008cites this paper
• Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications

  2007cites this paper